Disposition of 2635 shares by Jack Anders of Revolution Medicines at 45.4038 subject to Rule 16b-3

RVMD Stock  USD 43.07  2.15  5.25%   
About 56% of Revolution Medicines' investor base is looking to short. The analysis of the overall investor sentiment regarding Revolution Medicines suggests that many traders are alarmed. The current market sentiment, together with Revolution Medicines' historical and current headlines, can help investors time the market. In addition, many technical investors use Revolution Medicines stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Revolution Medicines Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at investing.com
Investing News at Macroaxis
  
Disposition of 2635 common stock at 45.4038 of Revolution Medicines by Jack Anders on 16th of December 2024. This event was filed by Revolution Medicines with SEC on 2024-12-16. Statement of changes in beneficial ownership - SEC Form 4

Revolution Medicines Current Investor Sentiment

Panic Vs Confidence

44

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Revolution Medicines' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Revolution Medicines.

Revolution Medicines Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Revolution Medicines can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Revolution Medicines Historical Investor Sentiment

Investor biases related to Revolution Medicines' public news can be used to forecast risks associated with an investment in Revolution. The trend in average sentiment can be used to explain how an investor holding Revolution can time the market purely based on public headlines and social activities around Revolution Medicines. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Revolution Medicines' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Revolution Medicines and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Revolution Medicines news discussions. The higher the estimate score, the more favorable the investor's outlook on Revolution Medicines.

Revolution Medicines Maximum Pain Price Across March 21st 2025 Option Contracts

Revolution Medicines' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Revolution Medicines close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Revolution Medicines' options.

Revolution Medicines Fundamental Analysis

We analyze Revolution Medicines' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revolution Medicines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revolution Medicines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Revolution Medicines is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Revolution Medicines Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Revolution Medicines stock to make a market-neutral strategy. Peer analysis of Revolution Medicines could also be used in its relative valuation, which is a method of valuing Revolution Medicines by comparing valuation metrics with similar companies.

Peers

Revolution Medicines Related Equities

GLUEMonte Rosa   7.68   
0%
100.0%
SANASana Biotechnology   7.38   
0%
96.0%
STOKStoke Therapeutics   4.57   
0%
59.0%
BDTXBlack Diamond   3.28   
0%
42.0%
KYMRKymera Therapeutics   2.66   
0%
34.0%
AKROAkero Therapeutics   2.52   
0%
32.0%
CCCCC4 Therapeutics   2.51   
0%
32.0%
AGIOAgios Pharm   2.40   
0%
31.0%
PTGXProtagonist Therapeutics   2.38   
0%
30.0%
RNAAvidity Biosciences   2.22   
0%
28.0%
NRIXNurix Therapeutics   1.88   
0%
24.0%
BPMCBlueprint Medicines   0.24   
3.0%
0%
PASGPassage Bio   4.92   
64.0%
0%

Complementary Tools for Revolution Stock analysis

When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals